Comparison of metabolism of sesamin and episesamin by drug-metabolizing enzymes in human liver.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 22752007)

Published in Drug Metab Dispos on June 29, 2012

Authors

Kaori Yasuda1, Shinichi Ikushiro, Shuto Wakayama, Toshimasa Itoh, Keiko Yamamoto, Masaki Kamakura, Eiji Munetsuna, Miho Ohta, Toshiyuki Sakaki

Author Affiliations

1: Department of Biotechnology, Faculty of Engineering, Toyama Prefectural University, Imizu, Toyama, Japan.

Articles by these authors

Revised nomenclature for avian telencephalon and some related brainstem nuclei. J Comp Neurol (2004) 3.69

Avian brains and a new understanding of vertebrate brain evolution. Nat Rev Neurosci (2005) 3.29

Structural basis for the activation of PPARgamma by oxidized fatty acids. Nat Struct Mol Biol (2008) 2.25

Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification. J Pediatr Hematol Oncol (2002) 1.94

Metabolism of vitamin D3 by cytochromes P450. Front Biosci (2005) 1.52

Upregulation of CREB-mediated transcription enhances both short- and long-term memory. J Neurosci (2011) 1.41

Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands. Proc Natl Acad Sci U S A (2009) 1.40

Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis. Thromb Res (2012) 1.38

Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. Drug Metab Dispos (2009) 1.34

Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. Mol Pharmacol (2005) 1.33

C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation. J Biol Chem (2004) 1.28

Molecular cloning and characterization of CYP719, a methylenedioxy bridge-forming enzyme that belongs to a novel P450 family, from cultured Coptis japonica cells. J Biol Chem (2003) 1.21

The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma. J Gastroenterol (2009) 1.13

Crystal structure of CYP105A1 (P450SU-1) in complex with 1alpha,25-dihydroxyvitamin D3. Biochemistry (2008) 1.08

Regulation of megalin expression in cultured proximal tubule cells by angiotensin II type 1A receptor- and insulin-mediated signaling cross talk. Endocrinology (2008) 1.07

Effectiveness of aquatic exercise and balneotherapy: a summary of systematic reviews based on randomized controlled trials of water immersion therapies. J Epidemiol (2009) 1.07

Analysis of structural features of bis-quaternary ammonium antimicrobial agents 4,4'-(alpha,omega-polymethylenedithio)bis (1-alkylpyridinium iodide)s using computational simulation. Bioorg Med Chem (2003) 1.07

Metabolism of vitamin D by human microsomal CYP2R1. Biochem Biophys Res Commun (2004) 1.06

The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients. Metabolism (2004) 1.05

Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker. Am J Physiol Regul Integr Comp Physiol (2006) 1.05

Structure-function relationships of vitamin D including ligand recognition by the vitamin D receptor. Med Res Rev (2003) 1.04

1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis. Clin J Am Soc Nephrol (2013) 1.04

The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages. Toxicol Sci (2009) 1.03

Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. J Affect Disord (2006) 1.03

The roles of cytochrome P450 enzymes in prostate cancer development and treatment. Anticancer Res (2012) 1.01

Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators. Mol Pharmacol (2007) 1.01

Identification of putative metabolites of docosahexaenoic acid as potent PPARgamma agonists and antidiabetic agents. Bioorg Med Chem Lett (2005) 0.99

Megalin and nonmuscle myosin heavy chain IIA interact with the adaptor protein Disabled-2 in proximal tubule cells. Kidney Int (2009) 0.99

A systematic review of nonrandomized controlled trials on the curative effects of aquatic exercise. Int J Gen Med (2011) 0.97

Characterization of rat and human CYP2J enzymes as Vitamin D 25-hydroxylases. Steroids (2006) 0.96

Seaweed intake and blood pressure levels in healthy pre-school Japanese children. Nutr J (2011) 0.96

Activation of testicular orphan receptor 4 by fatty acids. Biochim Biophys Acta (2009) 0.94

Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation. Arch Toxicol (2011) 0.94

The Avian Brain Nomenclature Forum: Terminology for a New Century in Comparative Neuroanatomy. J Comp Neurol (2004) 0.94

Identification of the amino acid residue of CYP27B1 responsible for binding of 25-hydroxyvitamin D3 whose mutation causes vitamin D-dependent rickets type 1. J Biol Chem (2005) 0.93

Gene expression profiling and identification of novel prognostic marker genes in neuroblastoma. Genes Chromosomes Cancer (2004) 0.93

Effects of coexpression of UGT1A9 on enzymatic activities of human UGT1A isoforms. Drug Metab Dispos (2007) 0.92

Insight into functional diversity of cytochrome P450 in the white-rot basidiomycete Phanerochaete chrysosporium: involvement of versatile monooxygenase. Biochem Biophys Res Commun (2011) 0.92

Structural determinants for vitamin D receptor response to endocrine and xenobiotic signals. Mol Endocrinol (2003) 0.91

Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer. Anticancer Res (2009) 0.91

Changes in microbiota population during fermentation of narezushi as revealed by pyrosequencing analysis. Biosci Biotechnol Biochem (2012) 0.91

Turtle-chicken chimera: an experimental approach to understanding evolutionary innovation in the turtle. Dev Dyn (2005) 0.91

Computed tomography morphology of the mandibular ramus in prognathism: effect on the medial osteotomy of the sagittal split ramus osteotomy. J Oral Maxillofac Surg (2003) 0.90

A possible mechanism for decrease in serum thyroxine level by polychlorinated biphenyls in Wistar and Gunn rats. Toxicol Sci (2004) 0.90

Megalin-mediated endocytosis of cystatin C in proximal tubule cells. Biochem Biophys Res Commun (2007) 0.90

Deep proteome mapping of mouse kidney based on OFFGel prefractionation reveals remarkable protein post- translational modifications. J Proteome Res (2014) 0.89

Rapidly growing leiomyoma in a postmenopausal woman. J Obstet Gynaecol Res (2004) 0.89

Target biopsy using magnifying endoscopy in clinical management of gastric mucosa-associated lymphoid tissue lymphoma. J Gastroenterol Hepatol (2011) 0.89

Human cytochrome P450-dependent differential metabolism among three 2α-substituted-1α,25-dihydroxyvitamin D(3) analogs. J Steroid Biochem Mol Biol (2012) 0.89

Structure-function analysis of vitamin D 24-hydroxylase (CYP24A1) by site-directed mutagenesis: amino acid residues responsible for species-based difference of CYP24A1 between humans and rats. Mol Pharmacol (2006) 0.89

Metabolism of sesamin by cytochrome P450 in human liver microsomes. Drug Metab Dispos (2010) 0.88

A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor. J Med Chem (2009) 0.88

Novel metabolism of 1 alpha,25-dihydroxyvitamin D3 with C24-C25 bond cleavage catalyzed by human CYP24A1. Biochemistry (2004) 0.88

Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans. Drug Metab Dispos (2007) 0.87

Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumors. Int J Oncol (2003) 0.87

Interactions between human UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A enzymes. J Pharm Sci (2010) 0.87

Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells. J Steroid Biochem Mol Biol (2011) 0.86

Interaction between mitochondrial CYP27B1 and adrenodoxin: role of arginine 458 of mouse CYP27B1. Biochemistry (2006) 0.86

The distinct agonistic properties of the phenylpyrazolosteroid cortivazol reveal interdomain communication within the glucocorticoid receptor. Mol Endocrinol (2005) 0.86

CYP24A1 as a potential target for cancer therapy. Anticancer Agents Med Chem (2014) 0.86

Endosurgical procedures for pediatric solid tumors. Pediatr Surg Int (2003) 0.86

Purification and characterization of mouse CYP27B1 overproduced by an Escherichia coli system coexpressing molecular chaperonins GroEL/ES. Biochem Biophys Res Commun (2004) 0.85

Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 by Streptomyces griseolus cytochrome P450SU-1. Biochem Biophys Res Commun (2004) 0.85

Interaction between vitamin D receptor and vitamin D ligands: two-dimensional alanine scanning mutational analysis. Chem Biol (2003) 0.85

Identification of a highly potent vitamin D receptor antagonist: (25S)-26-adamantyl-25-hydroxy-2-methylene-22,23-didehydro-19,27-dinor-20-epi-vitamin D3 (ADMI3). Arch Biochem Biophys (2006) 0.84

Metabolism of A-ring diastereomers of 1alpha,25-dihydroxyvitamin D3 by CYP24A1. Biochem Biophys Res Commun (2004) 0.84

Ligand recognition by vitamin D receptor: total alanine scanning mutational analysis of the residues lining the ligand binding pocket of vitamin D receptor. Curr Top Med Chem (2006) 0.84

Structure-based design of a highly active vitamin D hydroxylase from Streptomyces griseolus CYP105A1. Biochemistry (2008) 0.84

Metabolism of mono- and dichloro-dibenzo-p-dioxins by Phanerochaete chrysosporium cytochromes P450. Appl Microbiol Biotechnol (2010) 0.84

A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma. Br J Haematol (2014) 0.84

Eukaryotic-type aromatic amino acid decarboxylase from the root colonizer Pseudomonas putida is highly specific for 3,4-dihydroxyphenyl-L-alanine, an allelochemical in the rhizosphere. Microbiology (2012) 0.84

Cholecystokinin-A receptors regulate photic input pathways to the circadian clock. FASEB J (2007) 0.84